GHK's ability to improve tissue repair has been proven to be suitable for skin, lung connective tissue, bone tissue, liver and stomach wall
The eluates were combined and stored at 20 C
High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) represent the standard methods for peptide analysis
CJC-1295 (NO DAC) + Ipamorelin Blend Peptide Research Applications & Key Findings Growth Hormone Secretion Research Pituitary Function Studies Extensive research has examined the growth hormone secretagogue properties of the CJC-1295 + Ipamorelin combination across multiple species: Dose-dependent GH release demonstrated in rat anterior pituitary cell cultures with picomolar to micromolar peptide concentrations 2- to 10-fold increases in plasma growth hormone levels sustained for 6 days in human subjects following single CJC-1295 dose Preserved pulsatile secretion with ipamorelin addition, preventing continuous non-physiological stimulation Selective action on growth hormone release without affecting prolactin, ACTH, cortisol, FSH, or TSH levels Human trials with healthy subjects aged 21-61 years demonstrated sustained, dose-dependent increases in growth hormone and IGF-1 levels that were safe and well-tolerated at doses of 30-60 mcg/kg
Please note that an initial consultation or physician assessmentessential to tailoring your treatmentmay involve an additional fee ranging from $100 to $300
